The Obesity & Weight Management Alliance is excited to announce a call for poster submissions for its highly anticipated 2025 conference, taking place on March 7 at the Thistle London Marble Arch.

The House of Lords Food, Diet and Obesity Committee has issued a powerful call to action, highlighting the dire state of the UK’s food system and the escalating public health crisis caused by obesity. Appointed in January 2024 and re-established in July following the State Opening of Parliament, the Committee has presented a comprehensive report detailing a plan to overhaul the nation's approach to diet and health.

A new study has found a significant connection between the consumption of ultra-processed foods and the rise of metabolic disorders, including liver disease and insulin resistance, in children and adolescents living with obesity. The findings highlight the urgent need for improved dietary guidelines and public health measures to address this growing concern.

China’s National Health Commission (NHC) has introduced its first set of national guidelines to standardise the diagnosis and treatment of obesity, as the country grapples with a growing public health crisis.

George Yancopoulos, co-founder and chief scientific officer of Regeneron, has raised concerns about the long-term impact of popular weight-loss drugs, warning they could cause "more harm than good" due to rapid muscle loss.

The Obesity Health Alliance has launched its ambitious 10-year strategy, "Turning the Tide: A 10-Year Healthy Weight Strategy," aimed at reversing the rising levels of obesity across the UK.

A new study led by the National Institute on Aging (NIA) suggests that older adults living with obesity and metabolic issues can boost their brain health by following a healthy diet.

New results from the SELECT trial show that semaglutide 2.4 mg significantly reduces all-cause mortality in patients with obesity and cardiovascular disease, including deaths related to COVID-19.

Weight-loss medications may be a powerful tool in tackling obesity, but they are not the ultimate solution to the crisis, according to Professor Stephen Powis, NHS England's Medical Director.

Proposals to provide weight loss injections to unemployed people living with obesity could have a significant impact on both the economy and public health, according to Prime Minister Sir Keir Starmer.

A new population-based cohort study from Sweden has revealed significant links between overweight and obesity and adverse pregnancy outcomes, highlighting differences between Swedish-born and migrant women.

A new study presented at the 2024 Annual Meeting of the American Society for Metabolic and Bariatric Surgery (ASMBS) reveals that bariatric surgery is far more effective at maintaining weight loss compared to lifestyle changes and glucagon-like peptide-1 (GLP-1) medications.

Obesity rates in England are showing signs of stabilising, according to new figures released by the NHS. The data reveals that the number of children who are overweight has dropped to its lowest level since 2000, and obesity rates among adults have remained stable over the last five years.

A new study from the University of Copenhagen has identified lipid biomarkers in children and teenagers living with obesity that signal an increased risk of developing serious health issues.

A new international study has provided valuable insights, exploring the prevalence of obesity among adults living with and without type 1 diabetes across three different global regions.

A new study presented at the 2024 Annual Meeting of the American Society for Metabolic and Bariatric Surgery (ASMBS) reveals that bariatric surgery is far more effective at maintaining weight loss compared to lifestyle changes and glucagon-like peptide-1 (GLP-1) medications.

Adults with obesity or overweight and prediabetes had a 94 per cent lower risk of progressing to type 2 diabetes after taking tirzepatide, drugmaker Eli Lilly and Co. reported.

A significant increase in children walking and cycling to school has been credited for a notable reduction in childhood obesity rates in Guernsey.

A recent trial, published in The New England Journal of Medicine and presented at the European Association for the Study of Diabetes Obesity (EASD), demonstrated that liraglutide effectively lowered body mass index (BMI) in children, but the occurrence of side effects indicates a need for further research.